JOURNAL OF CONTROLLED RELEASE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2023-02-19 ms3000000829910165 来自河南省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：with editor多久呀

52 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2023-06-25 ms3000000478782113 来自湖南省

投稿命中率:25.0
偏重的研究方向：组织共;缓释
经验分享：投稿快一个月了还是Editor Invited

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2023-02-17 ms3000000829910165 来自河南省

偏重的研究方向：药理学
经验分享：请问一下，投稿需要所有作者点击确认吗

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2019-12-29 禾小呈

9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!

221 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2018-06-19 ms3555409846413331

我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。

199 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2019-02-12 ms4829174089086404

审稿速度:3.0 | 投稿命中率:50.0
经验分享：有没有农业科学方面投稿jci的经验？

182 0

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2018-12-26 ms8780191241558819

审稿速度:6.0 | 投稿命中率:25.0
经验分享：11.5 received
12.25 收到一审意见
五个审稿人，一个拒稿，一个大修，三个小修
不知道机会大不大

165 0

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2018-07-03 ms6597719114830456

三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。

193 0

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2018-06-29 ms5532630230796179

楼上bbs兄弟，你要做好review2个月的准备

172 0

[GetPortalCommentsPageByObjectIdResponse(id=2115427, encodeId=7d56211542e2e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Sun Feb 19 19:52:49 CST 2023, time=2023-02-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144663, encodeId=faea21446636a, content=投稿命中率:25.0 偏重的研究方向：组织共;缓释 经验分享：投稿快一个月了还是Editor Invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecba8287648, createdName=ms3000000478782113, createdTime=Sun Jun 25 15:38:05 CST 2023, time=2023-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115171, encodeId=f48a21151e168, content=偏重的研究方向：药理学 经验分享：请问一下，投稿需要所有作者点击确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17405591072, createdName=ms3000000829910165, createdTime=Fri Feb 17 23:30:28 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=582327, encodeId=2ca758232ed8, content=9.30投稿，期间editor换过一次，10.12 under review，11.6返回意见，12.16修回稿投出，12.28接收。审稿人特别nice！谢谢JCR!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/2c5be270413bdf8e26fdd765bc28a16c.jpg, createdBy=f8185133746, createdName=禾小呈, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844186, encodeId=fe8f84418627, content=我是第一次在jcr投稿，我是做纳米药物方面的，当时我自己推荐了一名审稿人，编辑又找了两个，一共三个审稿人，第一次审完后编辑给了一个拒稿，但又给了一个修改后重新投稿的机会，说明还是很认可文章的意义和价值。但一看审稿人的意见，真是不堪入目，觉得文章写得水平太差，讨论的描述不到位，体现不出文章的价值。但我还是想试试，于是按照编辑的意见修改后，1个月后重投，编辑还是找的之前的审稿人审的，第二次提的意见很具体很细，给了1个多月的修改时间，再修回后第二天就接受了。因为这个杂志只有接收、修改和拒稿三个处理结果，没有大修和小修之分。所以之前第一次拒稿相当于大修。还好编辑很好，给了一次修改后以新稿件重投的机会。在这里给大家点建议，只要编辑想要你的文章，即使审稿人意见不太好，也别灰心，不能放弃，只要文章有意义，就一定要坚持，认真修改，就一定会成功。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Tue Jun 19 17:41:22 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849660, encodeId=fdcb849660de, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有农业科学方面投稿jci的经验？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f75414053, createdName=ms4829174089086404, createdTime=Tue Feb 12 10:44:27 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848908, encodeId=f0ae8489082f, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：11.5 received 12.25 收到一审意见 五个审稿人，一个拒稿，一个大修，三个小修 不知道机会大不大 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Wed Dec 26 09:38:58 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844888, encodeId=99c8844888fe, content=三月初投稿，四月初收到一审意见。由于别的事情耽搁于六月初修回。七月初文章接收。三位审稿人从不同的方向给出了很专业的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Jul 03 23:53:24 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844585, encodeId=9f548445859d, content=楼上bbs兄弟，你要做好review2个月的准备 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Jun 29 12:53:41 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844584, encodeId=ee48844584be, content=杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Fri Jun 29 12:50:27 CST 2018, time=2018-06-29, status=1, ipAttribution=)]

2018-06-29 ms8782559743879884

杂志感觉都被把持了，我们做的抗菌方面，新意不错，结果也不少，编辑接口好文章收不过来据了，审稿也慢，3个月才通知还据稿，要快的同学慎投

170 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务